These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 7553254)

  • 1. [Puerperal inhibition of lactation with metergoline or bromocriptine].
    Fischer T; Streitmatter A; Gerede A; Frauendorf A; Krause M; Feige A
    Z Geburtshilfe Neonatol; 1995; 199(3):111-5. PubMed ID: 7553254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of puerperal lactation by metergoline.
    Crosignani PG; Lombroso GC; Caccamo A; Reschini E; Peracchi M
    Obstet Gynecol; 1978 Jan; 51(1):113-5. PubMed ID: 619329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Suppression of puerperal lactation by metergoline].
    Ohkura T; Ohya H; Hosoya N; Mori T; Watanabe H; Masaoka K; Kumasaka T
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jan; 35(1):61-7. PubMed ID: 6827165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metergoline as a lactation inhibitor.
    Caballero A; Palomo A; Molina CE; Albarrán FJ; Caballero A; Mena P
    J Reprod Med; 1982 Apr; 27(4):202-6. PubMed ID: 7097670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lactation by a long-acting bromocriptine.
    Peters F; Del Pozo E; Conti A; Breckwoldt M
    Obstet Gynecol; 1986 Jan; 67(1):82-5. PubMed ID: 3940343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experiences with the prolactin-inhibiting serotonin antagonist metergoline].
    Schneider WH; Huber H; Spona J
    Wien Klin Wochenschr; 1983 Jun; 95(13):452-5. PubMed ID: 6636776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin stimulation tests: different response patterns after bromocriptine, lisuride, and metergoline treatment of puerperal women.
    Bohnet HG; Kato K; De Moll H
    Obstet Gynecol; 1988 Jan; 71(1):53-5. PubMed ID: 3336541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metergoline as an inhibitor of prolactin release.
    Caballero A; Mena P; Caballero-Díaz JL; Caballero-Asensi A
    J Reprod Med; 1987 Feb; 32(2):115-9. PubMed ID: 3560070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of pseudopregnancy in the bitch with prolactin inhibitors metergoline and bromocriptine].
    Grünau B; Nolte I; Hoppen HO
    Tierarztl Prax; 1996 Apr; 24(2):149-55. PubMed ID: 8650684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromocriptine in an injectable retard form for puerperal lactation suppression: comparison with Estandron prolongatum.
    Defoort P; Thiery M; Baele G; Clement D; Dhont M
    Obstet Gynecol; 1987 Dec; 70(6):866-9. PubMed ID: 3684122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine agonistic effects as opposed to prolactin concentrations in plasma as the influencing factor on the duration of anoestrus in bitches.
    Okkens AC; Kooistra HS; Dieleman SJ; Bevers MM
    J Reprod Fertil Suppl; 1997; 51():55-8. PubMed ID: 9404271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition.
    BMJ; 1991 Jun; 302(6789):1367-71. PubMed ID: 1676318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metergoline versus bromocriptine in the prevention of puerperal lactation. A double-blind clinical trial.
    Scapin F; Buonaccorsi S; Tronconi G; Pellicciotta G; Pontiroli AE
    Eur J Clin Pharmacol; 1982; 22(2):181-3. PubMed ID: 7047172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of methergoline in inhibition of puerperal lactation].
    Iannotta F; Berra G
    Minerva Ginecol; 1979 May; 31(5):399-404. PubMed ID: 572517
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression of lactation. A comparison of bromocriptine and prostaglandin E2.
    England MJ; Tjallinks A; Hofmeyr J; Harber J
    J Reprod Med; 1988 Jul; 33(7):630-2. PubMed ID: 3172062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metergoline in the inhibition of puerperal lactation.
    Delitala G; Masala A; Alagna S; Devilla L; Lotti G
    Br Med J; 1977 Mar; 1(6063):744-6. PubMed ID: 322792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of bromocriptine to prevent puerperal lactation during neuroleptic treatment of chronic schizophrenia.
    Wolf R
    Pharmacopsychiatry; 1992 Sep; 25(5):240-2. PubMed ID: 1357683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline].
    Mussa A; Sandrucci S; Dogliotti L
    Minerva Med; 1979 Nov; 70(51):3493-8. PubMed ID: 522987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal bromocriptine: pharmacology and effect on serum prolactin in normal women.
    Vermesh M; Fossum GT; Kletzky OA
    Obstet Gynecol; 1988 Nov; 72(5):693-8. PubMed ID: 3173919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.